Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tyler Sandow

Vascular & Interventional Radiology New Orleans, LA Medical Doctor

NPI 1699033225 CMS profile 1393264

1514 Jefferson Hwy, Brent House Room 634, New Orleans, LA 70121

Open in the dashboard

General payments

$484,972

590 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$19,568 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Tyler Sandow of New Orleans, LA is reported in the CMS Open Payments database as having received $484,972 across 590 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $19,568 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $127,902 154
2024 General $129,366 142
2023 General $158,791 163
2022 General $64,047 71
2021 General $1,282 19
2020 General $985 13
2019 General $2,599 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tyler Sandow
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Tyler Sandow were reported at $127,902. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Tyler Sandow Vascular & Interventional Radiology median Middle half National median
2019 $2,599 $422 $125–$1,555 $163
2020 $985 $200 $68–$652 $114
2021 $1,282 $280 $99–$866 $132
2022 $64,047 $433 $137–$1,497 $149
2023 $158,791 $506 $152–$2,019 $160
2024 $129,366 $556 $175–$1,930 $164
2025 $127,902 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $444,342 408 payments
  2. Sirtex Medical Inc $14,467 11 payments
  3. Surefire Medical, Inc. $14,289 74 payments
  4. AstraZeneca UK Limited $1,880 1 payment
  5. Terumo Medical Corporation $1,416 18 payments
  6. Biocompatibles, Inc. $1,288 10 payments
  7. Guerbet LLC $1,151 1 payment
  8. Delcath Systems $1,097 5 payments
  9. Stryker Corporation $750 1 payment
  10. Okami Medical, Inc. $689 5 payments
  11. Other $3,603 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $382,819 134 payments
  2. Consulting Fee $35,793 18 payments
  3. Travel and Lodging $30,400 94 payments
  4. Food and Beverage $24,311 336 payments
  5. Honoraria $10,750 6 payments
  6. Grant $800 1 payment
  7. Education $100 1 payment
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 10 GBq $254,820 212 payments
  2. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $117,242 88 payments
  3. TheraSphere Administration Set $15,100 19 payments
  4. SIR-Spheres Microspheres $14,467 11 payments
  5. TRINAV INFUSION SYSTEM $14,267 73 payments
  6. General - Therapies $14,142 11 payments
  7. EMBOLD Fibered $6,692 10 payments
  8. General - Interventional Oncology $6,307 6 payments
  9. General - Embolics $4,797 4 payments
  10. Hepzato Kit $1,097 5 payments
  11. Other $8,926 123 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

31

Median for Diagnostic Radiology: 24

Drug cost

$140

Median for Diagnostic Radiology: $190

Branded share of claims

45.2%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $88
Oxycodone Hcl Generic 17 $51

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$84,740

Medicare's payments for the services billed

Medicare patients

173

Average age 68

Services billed

1,231

76 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 55%
Diabetes 51%
Heart failure 36%
Ischemic heart disease 36%
Arthritis 35%
Depression 32%
Cancer 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

590 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record